ReviewClinical and experimental medicine2026
Exosomal bioactive molecules: molecular regulation, functional heterogeneity, and translational implications in disease diagnostics and therapeutics.
Review in Clinical and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Urinary Extracellular Vesicle-Derived miRNAs as Regulators and Biomarkers in Diabetic Kidney Disease.International journal of molecular sciences · 2026Review
- Electrical Stimulation-Induced Modulation of Small Extracellular Vesicles in Regenerative Therapy.Tissue engineering and regenerative medicine · 2026Review
- The human breast milk microbiome: a landscape review of its composition, origins, and impact on infant health.Archives of microbiology · 2026Review
- Choosing the Right Extracellular Vesicle: Cross-Kingdom Immunological Functions Linking Molecular Mechanisms to Therapeutic Applications.Biomolecules · 2026Review
- The potential of bioengineered exosomes in regenerative medicine: a next generation therapy.Human cell · 2026Review
- Review
- Review
- Tendon dECM Composited with Chitosan with Loading Skin Precursor Stem Cell Exosome for Enhanced Diabetic Wound Healing.Gels (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exosomes are nanoscale extracellular vesicles that play a pivotal role in cell-to-cell communication by transporting a rich cargo of bioactive molecules, including proteins, lipids, and diverse nucleic acids. Recent discoveries have uncovered the complex molecular machinery behind exosome biogenesis and cargo loading, highlighting the roles of Endosomal Sorting Complex Required for Transport (ESCRT) complexes, lipid domains, RNA-binding proteins, and post-translational modifications. This review presents a comprehensive synthesis of the molecular pathways that regulate exosomal heterogeneity, with a focus on how these mechanisms govern the selective enrichment of biologically active cargo. We also discuss state-of-the-art technologies and omics platforms—such as ExoCarta and machine learning–based classifiers—used to decode exosomal content for diagnostic purposes. The clinical relevance of exosomes is examined through their roles in liquid biopsies for cancer, metabolic, and neurodegenerative diseases, emphasizing biomarker performance in terms of sensitivity and specificity. Furthermore, we explore the therapeutic potential of both native and engineered exosomes for targeted drug delivery, wound healing, and neuroregeneration, and provide insights into ongoing clinical trials. Despite growing interest, translational challenges persist, including standardization of isolation protocols, variability in cargo, targeting specificity, and regulatory constraints. Emerging strategies—ranging from synthetic exosome mimetics to AI-driven diagnostic algorithms—are rapidly reshaping the landscape of exosome-based precision medicine. This review consolidates current knowledge while proposing a forward-looking framework that integrates basic biology, engineering innovation, and clinical application, positioning exosomes as powerful agents in the future of diagnostics and therapeutics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.